Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Effect of Genetic Differences in Omeprazole Metabolism on Cure Rates for Helicobacter pylori Infection and Peptic Ulcer

Article Abstract:

Many patients with Helicobacter pylori infection may have different cure rates depending on genetic differences in the enzyme S-mephenytoin 4'-hydroxylase (CYP2C19). This liver enzyme metabolizes the drug omeprazole, which is used to treat Helicobacter pylori infection. Helicobacter pylori infection has been linked to peptic ulcer. In a study of 62 Japanese patients with Helicobacter pylori infection, those who metabolized omeprazole quickly had a 28% cure rate, those who metabolized the drug more slowly had a 60% cure rate and those who metabolized the drug the slowest had a 100% cure rate. Their ulcers healed at similar rates.

Author: Ishizaki, Takashi, Furuta, Takahisa, Ohashi, Kyoichi, Kamata, Takashi, Takashima, Misako, Kosuge, Kazuhiro, Kawasaki, Tsunehisa, Hanai, Hiroyuki, Kubota, Takahiro, Kaneko, Eizo
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 1998
Health aspects, Drug therapy, Helicobacter infections, Drug metabolism

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Combination treatment for peptic ulcers at high risk for recurrent bleeding

Article Abstract:

Endoscopic treatment combined with the proton pump inhibitor omeprazole is more effective for preventing recurrent peptic ulcer bleeding in patients with a high risk of recurrent bleeding than omeprazole alone, according to a study of 156 patients. Risk factors for recurrent bleeding include visible blood vessels during endoscopy or a blood clot on a blood vessel. Endoscopic treatment involves using a heat probe to seal a bleeding blood vessel.

Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2003
Prevention, Gastrointestinal bleeding, Gastrointestinal hemorrhage

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Treatment of patients at high risk for recurrent bleeding from a peptic ulcer

Article Abstract:

Patients who have a peptic ulcer that has bled in the past should be treated with thermal coagulation and an intravenous proton pump inhibitor such as omeprazole if endoscopy detects visible blood vessels or a blood clot on a blood vessel. Thermal coagulation can be delivered via endoscopy. The combined treatment may be more effective than proton pump inhibitors alone.

Author: Jensen, Dennis M.
Publisher: American College of Physicians
Publication Name: Annals of Internal Medicine
Subject: Health
ISSN: 0003-4819
Year: 2003
Editorial

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Peptic ulcer, Omeprazole, Care and treatment, Endoscopic surgery
Similar abstracts:
  • Abstracts: Virucides in prevention of HIV infection: research priorities. Genomic homogeneity of the AHU/IA-1,2 phenotype of Neisseria gonorrhoeae during its disappearance from an urban population
  • Abstracts: Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet
  • Abstracts: Withdrawal syndrome. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
  • Abstracts: Brian Belle-Fortune a voice from acute nursing. Providing care at home for cardiac surgery patients. Cardiac rehabilitation services: are the provided equitably?
  • Abstracts: Management of patients undergoing percutaneous coronary revascularization. Management of patients undergoing percutaneous coronary interventions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.